The Massachusetts Marine Fisheries Advisory Commission approved measures to limit the harvesting of female crabs during spawning season.
The population of horseshoe crabs has decreased in recent years, primarily due to their extensive use as bait by fishing crews and in biomedical manufacturing. Drug and devicemakers use the crabs’ blue blood to test vaccines, intravenous drugs and implantable medical devices for toxic bacteria.
Gov. Maura Healey is expected to approve the new regulation in the coming months.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
